The role of preoperative chemotherapy for esophageal cancer: When is surgery alone feasible?

Nature Clinical Practice Oncology

Volumn 2, Issue 4, 2005, Pages 172-173

  Chong, Geoff ^a   Cunningham, David ^a,b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CETUXIMAB; CISPLATIN; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; OXALIPLATIN;

ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DYSPHAGIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; FEASIBILITY STUDY; HUMAN; LOWER ESOPHAGUS SPHINCTER; META ANALYSIS; POSTOPERATIVE CARE; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; STOMACH ADENOCARCINOMA; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT INDICATION;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; PREOPERATIVE CARE; QUALITY OF LIFE;

EID: 20444463536     PISSN: 17434254     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncponc0126     Document Type: Review

References (9)

1. Kelsen D et al. (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339: 1979-1984
2. Brenner B et al. (2004) Treatment of localized esophageal cancer. Semin Oncol 31: 554-565
3. Medical Research Council Oesophageal Cancer Working Group (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359: 1727-1733
4. Malthaner R and Fenlon D (2003) Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev CD001556
5. Kaklamanos IG et al. (2003) Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 10: 754-761
6. Urschel JD et al. (2002) A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 183: 274-279
7. Allum W et al. (2003) Perioperative chemotherapy in operable gastric and lower oesophageal cancer: A randomised, controlled trial (the MAGIC trial, ISRCTN 93793971). [abstract] Proc Am Soc Clin Oncol 22: a998
8. Sumpter K et al. (2003) Randomised, multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer: confirmation of dose escalation. [abstract] Proc Am Soc Clin Oncol 22: a1031
9. Muro K et al. (2004) A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer. Ann Oncol 15: 955-959